Bill No. 109 aims to enhance health insurance coverage in Oklahoma by mandating that health benefit plans, including the Oklahoma Employees Insurance Plan, provide coverage for specific genetic testing and cancer imaging. The bill defines key terms such as "clinical utility," "evidence-based cancer imaging," and "genetic testing for an inherited mutation." It stipulates that coverage must be provided for clinical genetic testing for individuals with a personal or family history of cancer, as well as for evidence-based cancer imaging for those at increased risk of cancer, provided these tests are ordered by a healthcare provider and adhere to established clinical guidelines.

Additionally, the bill specifies that coverage for these services will not be subject to annual deductibles, copayments, or coinsurance limits. It also addresses the implications for health savings accounts, stating that the provisions will apply to qualified high deductible health plans after the minimum deductible is met, while still covering preventive care services regardless of deductible status. The act is set to take effect on November 1, 2025.